816463-38-4 Usage
Uses
Used in Pharmaceutical Industry:
2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-ol is used as a potential drug candidate for its possible biological activity, which may be harnessed to treat various diseases or conditions. The presence of the benzimidazole and quinoline rings, along with the hydroxyl and methyloxetanyl groups, could contribute to its pharmacological properties, making it a promising compound for drug development.
Used in Chemical Research:
In the field of chemical research, 2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-ol serves as a chemical probe to investigate biological processes and pathways. Its unique structure allows researchers to explore its interactions with biological targets, such as enzymes, receptors, or other proteins, providing insights into the molecular mechanisms underlying various biological phenomena.
Used in Drug Delivery Systems:
To enhance the bioavailability, delivery, and therapeutic efficacy of 2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-ol, it can be incorporated into drug delivery systems. These systems, which may include nanoparticles, liposomes, or other carriers, can protect the compound from degradation, facilitate its transport across biological barriers, and enable targeted delivery to specific tissues or cells, thereby improving its overall therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 816463-38-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,6 and 3 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 816463-38:
(8*8)+(7*1)+(6*6)+(5*4)+(4*6)+(3*3)+(2*3)+(1*8)=174
174 % 10 = 4
So 816463-38-4 is a valid CAS Registry Number.
816463-38-4Relevant articles and documents
SALT INDUCIBLE KINASE INHIBITORS
-
, (2022/02/15)
The present application provides compounds that modulate the activity of one or more salt inducible kinases (SIKs). Pharmaceutical composition and methods of treating diseases associated with abnormal expression and/or activity of one or more SIKs are also provided.
PROCESSES FOR THE PREPARATION OF 1-[(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES
-
Page 13; 14, (2008/06/13)
The present invention relates to a process for preparing a compound of the formula (I) or a pharmaceutically acceptable salt, prodrug, hydrate or solvate thereof, wherein R', R2, R3 and R4 are as defined herein. The compound of formula (I) is useful in the treatment of abnormal cell growth, such as cancer, in mammals.
